Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739342) titled 'Evaluating the Occurrence of DKA in People With Type I Diabetes' on July 28.

Study Type: Observational

Primary Sponsor: Abbott Diabetes Care

Condition: Type 1 Diabetes

Intervention: Device: Abbott Continuous Dual Glucose Ketone Monitoring System

Recruitment Status: Not recruiting

Date of First Enrollment: September 2026

Target Sample Size: 1200

Countries of Recruitment: New Zealand

To know more, visit https://clinicaltrials.gov/study/NCT07739342

Published by HT Digital Content Services with permission from Health Daily Digest....